What medications are routinely administered for rapid‑sequence induction before endotracheal intubation in children (0‑18 years)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications for Pediatric Rapid Sequence Intubation

For rapid sequence intubation in children, use a rapid-onset neuromuscular blocker (succinylcholine as first choice, or rocuronium if contraindicated) combined with an induction agent (etomidate, ketamine, or propofol depending on hemodynamic status), with consideration of atropine premedication particularly in infants. 1

Neuromuscular Blocking Agents

Succinylcholine remains the preferred first-line paralytic for pediatric RSI due to its rapid onset and short duration of action 1. The 2019 French guidelines provide a Grade 1+ recommendation for using rapid-onset muscle relaxants during classic RSI, with succinylcholine as the first choice 1. Recent 2026 data demonstrates that succinylcholine is associated with lower mortality rates compared to rocuronium (5.7% vs 8.9%, RR 0.65) 2.

Age-Based Succinylcholine Dosing:

  • Up to 1 month: 1.8 mg/kg
  • 1 month to 1 year: 2 mg/kg
  • 1 to 10 years: 1.2 mg/kg
  • Over 10 years: 1 mg/kg 1

Rocuronium (0.9-1.2 mg/kg) is the alternative when succinylcholine is contraindicated (neuromuscular disease risk, prolonged immobilization, burns, hyperkalemia concerns) 1. While a 2025 meta-analysis showed rocuronium provides superior intubating conditions with an odds ratio of 3.38 for excellent conditions 3, this must be weighed against its significantly longer duration of action and the mortality data favoring succinylcholine 2. Rocuronium use has been increasing in practice, now used in 64% of PICU intubations 4.

Induction Agents

Etomidate has become the dominant induction agent in pediatric emergency RSI, used in 78% of rapid sequence intubations 5. It offers hemodynamic stability with minimal cardiovascular depression, making it the safest choice for most clinical scenarios 6, 7.

Ketamine (typical dose 1-2 mg/kg IV) should be selected for patients with hemodynamic instability including shock, severe asthma, or cardiovascular compromise 4. Despite theoretical benefits, ketamine was not associated with lower rates of hypotension in a large multicenter study (8% vs 14%, p=0.08) 4, but it remains preferred in unstable patients and is used in 27% of overall intubations, rising to 39% in hemodynamically unstable patients 4.

Propofol is commonly used in practice (particularly in controlled settings) but carries significant risk of hypotension and should be avoided in hemodynamically unstable patients 6. Notably, propofol remains the most frequently used hypnotic even in premature and newborn infants despite off-label use 8.

Premedication Considerations

Atropine use varies significantly by age and practice setting. In PICU settings, vagolytics are administered in 37% of intubations overall, but this increases to 51% in infants compared to 28% in children over 1 year 4. The rationale is to prevent bradycardia from laryngoscopy, particularly in younger infants who are more vagally responsive.

Premedication practices have declined dramatically in emergency departments, dropping to less than 30% by recent years 5. However, in NICU settings for very low birth weight infants, increasing premedication use (including vagolytic and analgesic agents) from 25.7% to 93.4% reduced adverse events from 41.4% to 14.4% 9.

Fentanyl is commonly used as an adjunct analgesic (used in 64% of PICU intubations) 4, though it should be used cautiously due to potential for chest wall rigidity and hypotension.

Critical Practice Points

  • Muscle relaxation is strongly recommended - 92% of PICU intubations use neuromuscular blockade 4, and guidelines give this a Grade 1+ recommendation 1
  • Avoid intubation without paralysis in RSI scenarios, as this significantly reduces first-attempt success rates 5
  • Infants have the highest risk of first-attempt failure (relative risk 2.3 compared to older children) 5
  • Consider sugammadex availability (16 mg/kg) when choosing rocuronium, particularly if difficult airway is anticipated, though it remains off-label in some regions 1
  • Rapid sequence intubation provides better outcomes than sedation without paralysis (odds ratio 3.4 for first-attempt success) 5

The combination of succinylcholine with etomidate appears to provide the best overall outcomes for standard pediatric RSI 2, with adjustments to ketamine for hemodynamic instability and rocuronium when succinylcholine is contraindicated.

References

Guideline

management of the child's airway under anaesthesia: the french guidelines.

Anaesthesia Critical Care & Pain Medicine, 2019

Research

Current medication practice and tracheal intubation safety outcomes from a prospective multicenter observational cohort study.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2015

Research

Controversies in rapid sequence intubation in children.

Current opinion in pediatrics, 2005

Research

Rapid-sequence intubation and the role of the emergency department pharmacist.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.